Drugs of Abuse: How Clinical Pharmacology Brings Clarity to the Shadows.

Nafziger, Anne N; White, C Michael

Nafziger, Anne N; White, C Michael.

Affiliation

Nafziger AN; Bertino Consulting, Schenectady, NY, School of Pharmacy & Pharmaceutical Sciences, Department of Pharmacy Practice, University at Buffalo, State University of New York, Buffalo, New York, USA.
White CM; BOT Distinguished Professor and Chair, Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, Co-Director, HOPES Research Group, UConn and Hartford Hospital, Hartford, Connecticut, USA.

J Clin Pharmacol ; 61 Suppl 2: S6-S9, 2021 08.

Article in En | MEDLINE | ID: mdl-34396550

Subject(s)

Illicit Drugs/pharmacology; Pharmacology, Clinical; Substance-Related Disorders/epidemiology; Counterfeit Drugs; Humans; Illicit Drugs/adverse effects; Prescription Drug Misuse

Key words

cannabinoids; central nervous system simulants; clinical pharmacology; drug abuse; electronic nicotine delivery systems; gabapentinoids; illicit drugs; opioid use; substance withdrawal syndrome; toxicology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacology, Clinical / Illicit Drugs / Substance-Related Disorders Limits: Humans Language: En Journal: J Clin Pharmacol Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google